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Glomerulonephritis associated with MRSA infection: A possible role of
bacterial superantigen. We report 10 cases of glomerulonephritis follow-
ing methicillin-resistant Staphylococcus aureus (MRSA) infection. The
clinical features of this syndrome were an abrupt or insidious onset of
rapidly progressive glomerulonephritis (RPGN) with nephrotic syndrome
and occasionally purpura, following MRSA infection. The renal histologic
findings showed a variety of types of proliferative glomerulonephritis with
varying degrees of crescent formation; immunofluorescence revealed of
glomerular deposition of IgA, IgG, and C3. Laboratory findings showed
polyclonal increases of serum IgA and IgG, with high levels of circulating
immune complexes (ICs). Increased numbers of DRCD4, and
DRCD8 T cells were observed in the peripheral circulation, with a high
frequency of T cell receptor (TCR) V,3÷ cells. MRSA produced entero-
toxins C and A and toxic shock syndrome toxin (TSST)-1, all of which are
known to act as superantigens. From the above observations, we speculate
that post-MRSA glomerulonephritis may be induced by superantigens
causing production of high levels of cytokines, and polyclonal activation of
IgG and IgA. The formation of ICs containing IgA and IgG in the
circulation result in development of glomerulonephritis and vasculitis.
Accordingly, microbial superantigens may play an important role in the
pathogenesis of this unique syndrome of nephritis and vasculitis.
The histopathologic changes of post-infectious glomerulone-
phritis are variable and depend on a number of factors related to
both the host and the infecting organism. The association between
group A hemolytic streptococcal infection and the subsequent
development of acute nephritis is well recognized. While post-
streptococcal glomerulonephritis is now relatively uncommon in
developed countries, it has become apparent that other infections
may produce a variety of clinical syndromes and glomerular
lesions [1]. Many factors are likely involved in the changing
epidemiology of infection-associated glomerular disease, includ-
ing socioeconomic status and environmental health.
In spite of pharmacologic advances, many antibiotic-resistant
bacterial infections are being reported. Infection with MRSA is
one of the major opportunistic hospital infections [2], and patients
with MRSA infection frequently develop septicemia or toxic
shock syndrome (TSS), which are caused by the enterotoxins
(SEs) of MRSA [3]. Staphylococcal infections have also been
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identified as causal agents of glomerulonephritis. Most reports
linking staphylococcal infection and glomerulonephritis have em-
phasized two clinical settings: Staphylococcus epidermidis bactere-
mia with ventriculo-jugular shunts (VJS), and Staphylococcus
aureus bacteremia with endocarditis [4—6].
SEs have recently been recognized to act as "superantigens"
[7—10]. SEs can bind directly to major histocompatibility complex(MHC) class II molecules on antigen presenting cells and the
specific V chain of the TCR. The SEs stimulate resting T cells to
proliferate and cause massive T cell activation and a subsequent
release of T cell-derived lymphokines such as interleukin (IL)-2,
IL-6, and other cytokines including IL-i, TNF and interferon-y
[11—13]. TCRV cells are usually present at levels less than 5%
in peripheral blood lymphocytes [7—10, 13].
We report 10 cases of MRSA-associated glomerulonephritis
with polyclonal increases of IgA and IgG and massive T cell
activation. In this study, we analyzed the clinical and immunologic
characteristics of these patients and investigated the role of SEs as
superantigens in the pathogenesis of this unique form of glomer-
ulonephritis.
Methods
Patients
We studied 10 patients with glomerulonephritis occurring after
MRSA infection and 10 patients with MRSA infection without
nephritis; all patients were admitted to Tsukuba University Hos-
pital (Table 1). Fifty-one patients with IgA nephropathy and 24
normal individuals were used as controls. The criteria of clinical
syndromes were defined by WHO criteria [14]. Case definition of
toxic shock syndrome was as defined by Reingold et al [15].
Bacteriologic analysis
Identification of MRSA. Samples from patients were cultured
and the sensitivities of bacteria to antibiotics were tested using an
antibiotic sensitivity kit (Eiken Kagaku Co., Tokyo, Japan).
Identification of coagulase types and SEs. Culture supernatants
were assayed with a staphylococcal enterotoxin detection kit using
reversed passive latex agglutination (Denka Seiken Co., Tokyo,
Japan) and immunoblotting; coagulase types were determined
using a detection kit (Denka Seiken).
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Table 1. Patient profiles and clinical findings in patients with nephritis, and underlying conditions, types of infections, and types of bacteria
Onset after
infection
No. Sex Age weeks
Clinical syndromes
of renal disease Purpura Outcome of GN
A MRSA infection with nephritis
1 M 21 16 RPGN + NS yes HD
2 M 27 5 NS yes improved
3 M 60 11 RPGN no improved4 M 61 4 RPGN + NS no improved
5 M 69 6 NS no death due to underlying disease
6 M 65 2 RPGN + NS no HD to Scr 2.2 mgldl (improved)
7 M 84 2 RPGN + NS no death due to underlying disease
8 F 66 5 RPGN no death due to underlying disease
9 M 60 8 RPGN + NS no HD
10 M 65 10 NS no improved
No. Sex Age Underlying conditions Types of infection Bacteria Types of coagulase and enterotoxin
B MRSA infection with nephritis
1 M 21 trauma abscess of abdominal
cavity + sepsis
MRSA Coagulase type II, enterotoxin C and TSST-1
2 M 27 retroperitoneal tumor abscess of abdominal MRSA Coagulase type II, enterotoxin C and TSST-1
3 M 60 phlegmone
cavity + sepsis
phlegmone + sepsis St. pyogenes!
MRSA
Coagulase type II, enterotoxin A, B, C and
TSST-1
4 M 61 postthymectomy- abscess of pleural MRSA Coagulase type II, enterotoxin A, C and TSST-1
abscess cavity + sepsis5 M 69 lung cancer pneumonia + sepsis MRSA Coagulase type II, enterotoxin A, C and TSST-1
6 M 65 arthritis purulent arthritis +
sepsis
MRSA Coagulase type II, enterotoxin C and TSST-1
7 M 84 subdural hematoma pneumonia + sepsis MRSA ND
8 F 66 gall bladder cancer abscess of abdominal
cavity + sepsis
MRSA Coagulase type II, enterotoxin A, C and TSST-1
9 M 60 peritonitis, abscess of abdominal MRSA Coagulase type II, enterotoxin A, C and TSST-1
pancreatitis cavity + sepsis
10 M 65 fistula-colon abscess of abdominal
cavity + sepsis
MRSA Coagulase type II, enterotoxin A, C and TSST-1
C MRSA infection without nephritis
1 F 58 acute pancreatitis abscess of abdominal
cavity + sepsis
MRSA Coagulase type II, enterotoxin A and TSST-1
2 M 68 IVH-sepsis pneumonia + sepsis MRSA Coagulase type II, enterotoxin C and TSST-1
3 M 74 ureter cancer, ARF pneumonia + sepsis MRSA Coagulase type II, enterotoxin A and TSST-1
due to shock
4 F 79 perforation of small abscess of abdominal MRSA Coagulase type II, enterotoxin C and TSST-1
intestine cavity + sepsis
5 M 65 meningioma-postop brain abscess +
sepsis
MRSA Coagulase type II, enterotoxin C and TSST-1
6 F 29 ulcer of leg abscess of abdominal
cavity + sepsis
MRSA Coagulase type II, enterotoxin C and TSST-1
7 M 51 traffic accident infection of skin
graft + sepsis
MRSA Coagulase type II, enterotoxin A and C
8 M 50 colon cancer, ileus abscess of abdominal
cavity + sepsis
MRSA Coagulase type II, enterotoxin A, C and TSST-1
9 M 54 emphysema pneumonia + sepsis MRSA Coagulase type II, enterotoxin A, C and TSST-1
10 M 68 myocardial infarction sepsis MRSA Coagulase type II, enterotoxin C and TSST-1
Clinical syndromes of renal disease are defined by the WHO criteria [10]. Abbreviations are: RPGN, rapidly progressive glomerulonephritis; NS,
nephrotic syndrome; Onset, onset of glomerulonephritis (occurrence of proteinuria, hematuria, and edema); MRSA, methicillin-resistant Staphylococ-
cus aureus; St. pyogenes, Streptococcus pyogenes; TSST-1, toxic shock syndrome toxin-i; ND, not done.
Histologic examination with n-hexane in solid carbon-dioxide-acetone for immunofluo-
Renal biopsy was performed in five cases and autopsy was rescence microscopy (IF). The 4-j.rm tissue sections were stained
performed in one case. For light microscopy, tissues were fixed in in the standard manner, using FITC-labeled Ab against human
buffered formalin, processed in the usual fashion, and stained with IgU, IgA, 1gM, C3, and rabbit anti-SEs (Cappel, Organon
hematoxylin-eosin, periodic acid-Schiff and periodic acid-silver Teknika Corp. West Chester, PA, USA): A, B, C, D, and TSST-1
methenamine reagent. A portion of each specimen was frozen Abs (Denka Seiken Co.) or mouse monoclonal Abs (Chemunex,
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Maisons-Alfort, France), rabbit-anti-protein A Ab (Rockland,
Inc., Gilbertsville, PA, USA), mouse monoclonal anti-Staphylo-
coccus aureus (Chemicon International, Inc., Temecula, CA,
USA) and FITC-anti-rabbit or FITC-anti-mouse IgG or 1gM
(Cappel), as secondary Abs.
Lymphocyte subset analysis
Peripheral lymphocytes from patients with MRSA infection
with nephritis, MRSA infection without nephritis, healthy volun-
teers and patients with IgA nephropathy were obtained. Mono-
nuclear cells were isolated by density centrifugation. Lymphocyte
subsets were analyzed on an FACScan (Becton Dickinson Immu-
nocytometory Systems, San Jose, CA, USA), using the following
biotin, phycoerythrin (PE) or FITC-labeled monoclonal Abs:
anti-CD4 (Leu-3a) (mouse IgGi), anti-CD3 (Leu-4) (mouse
IgGi), anti-CD19 (Leu-12) (mouse IgGi), and anti-HLA-DR
(mouse IgG2a) Abs (Beckton Dickinson). The variable regions of
human TCR were analyzed by three color analysis, using the Ab
TCR screening panel iF, which contained Abs against six V
subsets [V5.2 + 5.3Ag (V5a), V5.3Ag (V5b), V5.1 (V5c),
V6.7 (V,36a), V8 subfamily (V,38a), V12.1 (V12a)], one Va2
subfamily (aV2a) (T Cell Diagnostics Inc., Cambridge, MA,
USA) and anti-CD4, CD8 Abs.
Immune complex (IC) detection by ELISA
Serum samples were added to ELISA plates, and coated with
mouse monoclonal anti-C3d Ab, and peroxidase-conjugated
monoclonal Ab anti-human IgG (mouse IgGi) and monoclonal
Ab anti-human IgA (mouse IgGi) were used as secondary Abs
(immune complex detection test, QUIDEL, Advanced Research
Technologies, San Diego, CA, USA). Amounts of IgG ICs were
expressed as equivalent of human IgG, and those of IgA ICs
were expressed as OD units.
Detection of autoantibodies
Anti-glomerular basement membrane (GBM) Ab and anti-
nuclear Ab were analyzed by indirect immunofluorescence using
normal human kidney sections and HEp-2 cells (HEPANA test;
Medical & Biological Laboratories, Nagoya, Japan). Anti-neutro-
phil cytoplasmic antibodies (ANCA) were detected by indirect
immunofluorescence using human neutrophils. Cryoglobulins
were assayed by the cryoglobulin precipitation method. Rheuma-
toid factor (RF) was detected by the latex agglutination test.
Statistical analysis
Statistical analysis for T cell-subsets was performed by analysis
of variance (ANOVA) and by the Mann-Whitney test. Differences
in enterotoxins between patients with nephritis and without
nephritis were analyzed by Fisher's exact probability test.
Results
Clinical features of patients with MRSA infection with or without
nephritis and outcome of the nephritis
The clinical features of the 10 patients with MRSA with
glomerulonephritis are shown in Table 1A. Within 10 weeks after
the onset of MRSA infections, massive proteinuria with hematu-
na appeared in 8 of the 10 cases. In 7 cases the clinical
presentation was RPGN, and 8 patients had the nephrotic syn-
drome. Purpura was observed in 2 cases. Two patients ultimately
required therapy with continuous hemodialysis (HD). In 5 cases,
the nephritis remitted with cure of the infection. None of these 10
patients had TSS or evidence of endocarditis, or hypotension
during the course of nephritis.
In case 3 the cause of infection was a scratch wound. Bacteria
found in the early stage of infection were St. pyogenes and MRSA.
This patient developed ARF due to aminoglycosides and received
HD. He recovered four weeks after the initiation of HD. At that
point, there was no proteinuria or hypotension, and no evidence
of TSS or endocarditis. Lymphocyte subsets were measured
before the onset of glomerulonephritis. Four weeks after the last
HD therapy his urinary protein gradually increased, accompanied
by a polyclonal rise in IgO and IgA and development of RPGN.
In case 6 the cause of infection was trauma. The patient had
septicemia and also had arthritis due to MRSA infection. He
received aminoglycosides and developed ARF. After recovery
from ARF, proteinuria developed with progression of RPGN with
nephrotic syndrome. There was no evidence of TSS, or endocar-
ditis, as judged by echocardiography.
Among 10 cases of MRSA infection without nephritis, 7 cases
showed varying levels of hematuria at the start of observation, and
3 cases still showed hematuria at the end of observation. None of
these patients showed deterioration in renal function.
Bacteriologic analysis
Results of the bacteriologic analysis are shown in Table 1 B and
C. MRSAs were detected in all cases, and St. pyogenes was also
detected in one case. The coagulase was consistently type II in all
cases, and SE-C, A, and TSST-1 were common toxins in these
patients. There were no significant differences of SE types be-
tween patients with MRSA infection with nephritis and those
without nephritis ( 0.867, P = 0.833).
Laboratoiy data
The serum levels of IgA in patients with nephritis were signif-
icantly higher than those in patients without nephritis (P <0.0004;
Tables 2 and 3).
In the control group, the levels of serum IgA were increased in
four cases and primary selective IgA deficiency was observed in
one case (case 5).
The serum complement levels were within normal limits, or
elevated in patients with nephritis compared to normal individu-
als.
Autoantibodies, including anti-DNA Ab, anti-nuclear Abs, RF,
ANCA, and Ab anti-GBM were not detected. Ciyoglobulins were
also not detected.
Histopathological study
Various types of proliferative glomerulonephritis with varying
degrees of crescent formation were observed in six cases (Table 4,
Figure 1). Mononuclear cell infiltration into the tubular epithe-
hum and the interstitium (tubulointerstitial nephritis) was ob-
served. On IF examination IgA, IgG, and C3 deposits in both the
mesangium and peripheral capillary walls were observed. There
was no significant staining for SEs (SE-A, B, C, D, E, TSST-1),
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Table 2. Laboratory data at the onset, the nadir of renal function, and the end of observation
Urine protein H
at onset
No. giday
.
ematuria
at onset
grade
Scr at
onset
mgldl
.Maxurine
protein
giday
Max Scr
mg/dl
Urine
protein Hematuria Scr
at the end of follow-up
A MRSA infection with nephritis
1 1.82 3+ 0.60 9.00 HD HD HD HD
2 12.00 2+ 0.50 20.00 1.5 0.2 (—) 0.6
3 0.30 3+ 1.20 1.20 2 (—) (—) 1.9
4 0.40 2+ 0.80 5.40 2.5 4.3 3+ 1.5
5 2.20 1+ 1.00 5.10 1.8 7.6 1+ 1.7
6 1.00 3+ 9.90 5.50 HD-2.1 0.6 3+ 2.2
7 3.00 1+ 1.10 10.00 3.5 2 3+ 3.5
8 1+ 3+ 1.5 2.5 7.3 1.4 3+ 7.3
9 1+ 3+ 1 16.4 HD HD HD HD
10 1.4 2+ 1.3 6.4 1.3 0.1 2+ 1.3
B MRSA infection without nephritis
1 (—1+—) 2+ 0.5 (—) 0.6 (—) (—) 0.5
2 (+/—)
3 (—)
3+
3+
2.5
1.3
(+1—)
(+1—)
3.7
HD
0.26
HD
2+
HD
2.2a
HDb
4 (+1—) 1+ 0.4 (—) 0.5 (—) (+/—) 0.5
5 (+1—) 3+ 0.9 (—) 0.9 (—) (—) 0.5
6 (—) (—) 0.6 (—) 0.9 (—) (—) 0.6
7 (+1—) 1+ 0.6 (+1—) 0.8 (—) 3+ 0.6
8 (—) (—) 0.8 (—) 1 (—) (—) 1.1
9 (—) 3+ 0.6 (+1—) 1 (—) (—) 0.8
10 (—) (+1—) 1.1 (—) 1.1 (—) 1+ 1.1
Abbreviations are: 5Cr' serum creatinine; HD, hemodialysis.
Due to aminoglycoside
b Due to DIC/MOF
Staphylococcus aureus (SA) antigen or protein A from SA in the
glomeruli. Cutaneous biopsy in two patients revealed leukocyto-
elastic vasculitis with IgA deposition.
Lymphocyte subsets
We analyzed the lymphocyte subsets in 10 cases with MRSA
infection with nephritis, and compared those to 10 cases with
MRSA infection without nephritis, 24 normal individuals, and 49
patients with IgA nephropathy. The ratios of both DRCD4 and
DRCD8 cells were increased in patients with MRSA infection
with glomerulonephritis, when compared with those of normal
individuals and patients with IgA nephropathy (Fig. 2 A, B).
We analyzed the variable regions of TCR in 10 patients with
MRSA infection with nephritis, 10 patients with MRSA infection
without nephritis, 6 patients with IgA nephropathy, and 10 normal
individuals. In patients with MRSA infection with nephritis, the
ratios of TCR-V0s [V,35.lt V0(5.2 + 5.3), V06.7, V08 family,
V012. 1k], were significantly increased (Fig. 2C). In contrast, in
patients with MRSA infection without nephritis, TCR-V0s ratios
were significantly lower than those in patients with MRSA
infection with nephritis.
In one patient (case 3), we followed changes in the V0 regions
from before onset through the course of the disease. The ratios of
TCR-V05.1 at onset were significantly increased compared to
those before onset; these ratios gradually decreased during van-
comycin therapy (Fig. 3C). The ratios of DRCD4 and
DRCD8 cells at the onset were significantly increased com-
pared to those before the onset (Fig. 3 A, B). The subsets of cells
that were increased were mainly TCRCD4CD8 [double
negative (DN) cells] in this case. The ratio of these TCR-V0DN
cells was five times higher than that before the onset of nephritis
Table 3. Immunologic data at the nadir of renal function
IgG IgA 1gM
N.R (800—2000) (80—400) (30—300)
C3
(40—120)
C4
(13—59)
AutoantibodiesNo. mg/dl
A MRSA infection with nephritis
1 2950 1143 160 87 28 (—)
2 1286 534 110 73 48 (—)
3 2677 698 116 83 45 (—)
4 1432 569 83 76 29 (—)
5 2422 630 104 110 48 (—)
6 2040 574 104 51 29 (—)
7 1370 512 130 89 53 (—)
8 4292 656 534 64 22 (—)
9 1644 650 95 93 43.7 (—)
10 2460 601 196 124 35 (—)
B MRSA infection without nephritis
1 2565 441 126 99 41 (—)
2 1663 421 91 85 46 (—)3 ND ND ND ND ND ND
4 2619 418 176 89 29 (—)
5 3101 8 241 115 57 (—)
6 974 191 258 151 44 (—)
7 1896 269 149 137 44 (—)
8 1526 471 339 113 59 (—)
9 683 165 161 100 52 (—)
10 ND ND ND ND ND ND
Abbreviations are: NR, normal range; ND, not done.
Autoantibodies are: anti-glomerular basement membrane Ab, anti-
neutrophil cytoplasma Abs, anti-DNA Ab, anti-nuclear Abs, ciyoglobu-
lins, rheumatoid factor.
(Fig. 4). In all cases combined, TCR V0s cells and TCRDN
cells were significantly increased compared to those in the other
groups (Fig. 5).
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Table 4. Renal histopathologic findings
LM findings IF findings
No. Glomerular lesion TIN IgG IgA 1gM C3
1 Diffuse mesangioproliferative GN with crescents 3+ P(++)M(+—) P(+)M(++) P(+—)M(—) P(+)M(++)
2 Mesangiocapillary GN with crescents 1+ P(++)M(+) P(++)M(+) P(—)M(--) P(++)M(+)
3 Segmental necrotizing GN 1+ P(++)M(+) P(++)M(++) P(—)M(---) P(++)M(++)
4 ND ND ND ND ND ND
5 ND ND ND ND ND ND
6 Diffuse endo-mesangioproliferative GN 2+ P(+)M(++) P(+)M(+—) P(+—)M(—) P(++)M(+)
7 ND ND ND ND ND ND
8 Mild mesangial proliferative GN P(+)M(+) P(+)M(+) P(+—)M(—) P(+)M(+)
9 ND ND ND ND ND ND
10 Mild mesangial proliferative GN P(+)M(+) P(+)M(+) P(+—)M(—) P(+)M(+)
Abbreviations are: LM, light microscopy; IF, immunofluorescence microscopy; TIN, tubulointerstitial nephritis; P, peripheral capillary wall; M,
mesangium; ND, not done.
Fig. 1. Light microscopic finding of case 1(A). Diffuse mesangioproliferative glomerulonephritis with crescent formation was observed. Mononuclear cell
infiltration into tubular epithelium and the interstitium was also observed. (Periodic acid-Schiff stain X 66). Depositions of IgA (B), IgG (C) and C3
(D) in both mesangium and peripheral capillary walls were observed.
IC detection have subsequently been isolated in many other parts of the world,
Amounts of IgA-ICs in patients with MRSA infection and including Japan. As a nosocomial pathogen, MRSA infection is a
nephritis were significantly increased compared to those with serious problem from both clinical and epidemiologic standpoints.
MRSA infection without nephritis and normal individuals (Fig. 6). Staphylococcal infections were identified as causal agents of
glomerulonephritis by Powell in 1961 [4]. Reports of staphylococ-
Discussion cal infection with glomerulonephritis have described two main
MRSA strains were initially detected in 1961 in the United types: Staphylococcus epidermidis bacteremia in children with VJS
Kingdom [161 shortly after methicillin came into clinical use. They [5, 17—19] and Staphylococcus aureus bacteremia in adults with
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Fig. 2. Lymphocyte subsets. (A) DRCD4
cells, (B) DRCD8 cells, (C) TCRV,3 cells in
patients with MRSA infections: with nephritis(, N = 10), without nephritis (,N = 10),
with IgA nephropathy (, N = 6), or in
normal individuals ( , N = 10). Data(percentages of cells) are expressed as mean
In patients with MRSA infection with
nephritis, the ratios of TCR V85.1, V,3(5.2 +
5.3), V0 6.7 , V08 family and V012.1 cells,
especially V0 5.1k cells, significantly increased
compared to those in the other 3 groups. *p <
0.05 vs. MRSA infection without nephritis,
normal. jP < 0.05 vs. MRSA infection without
nephritis.
endocarditis [6, 201. The clinical course is variable, but usually
mild in VJS nephritis. The complement levels are low in the
majority of patients [5, 17—191. The histologic findings in VJS
nephritis show either mesangial hypercellularity or diffuse prolif-
erative glomerulonephritis often with a lobulated or mesangio-
capillary type. Immunofluorescence microscopy in VJS nephritis
usually shows IgG, C3, and 1gM in capillary loops or mesangium.
In constant, patients with glomerulonephritis and acute Staphylo-
coccal aureus endocarditis generally show signs of sepsis and acute
renal failure. The serum C3 and C4 levels are usually decreased
[6, 20]. Pathologic findings are acute proliferative glomerulone-
phritis, and in some cases, a membranoproliferative type. Immu-
nofluorescence usually reveals granular deposition of C3 but no
IgA [5, 18].
Spector et a! have reported three patients with visceral Staph-
ylococcus aureus infection without endocarditis who developed
acute glomerulonephritis [21]. Renal biopsy in two patients
showed mesangial proliferative glomerulonephritis and mesangial
deposits containing IgA, IgG and C3. These findings were differ-
ent from those found in the well-understood syndromes of
glomerulonephritis associated with endocarditis or infected VJS.
We report 10 patients with a unique syndrome characterized by
an abrupt or insidious onset of RPGN with nephrotic syndrome
following MRSA infection. The renal histology showed prolifer-
ative glomerulonephritis with varying degrees of crescent forma-
tion, and the glomerular deposition of IgA, IgG, and C3. Labo-
ratory findings showed a polyclonal increase in serum IgA and
IgG, with high levels of circulating ICs (Fig. 6). These findings are
similar to those reported by Spector et al [21].
Recently, SEs have attracted attention as bacterial superanti-
gens, because of their unique role in T cell activation [7—11, 13].
SEs can bind directly to MHC class II molecules on the antigen-
presenting cell and specific V0 chain of TCR. Binding to class II
molecules, on macrophages could activate these cells to release
cytokines. The production of macrophage-derived mediators such
as IL-i and TNF have been demonstrated after toxin stimulation
of human cells [11—13]. These cytokines are known to be patho-
genic at high levels, causing inflammation and tissue damage [22,
23]. Recently, there have been reports of a role of SEs in the
pathogenesis of human diseases, including TSS [3, 23], rheuma-
toid arthritis [24], Kawasaki disease [25], AIDS [261, Sjogren
syndrome [27], and multiple sclerosis [28].
Paliard et al reported that in patients with rheumatoid arthritis
the frequency of V014 T cells was significantly higher in the
synovial fluid of affected joints than in the peripheral blood [24].
Sumida et al have reported that the repertoires of V02 and
V013 genes were predominantly expressed on the T cells of lip
specimens of patients with Sjögren syndrome, suggesting a possi-
ble role in triggering the autoimmunity of this disease [27]. Abe et
al have reported that the acute phase of Kawasaki disease is
associated with the expansion of T cells expressing the V02 and
V08.1 gene segments [251. Thus the increase of TCRV0 cells
is thought to be a marker of superantigen-related diseases.
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Fig. 3. Changes in lymphocyte subsets in case 3.
(A) DRCD4 cells, (B) DRCD8 cells, (C)
TCR-V8 regions. The ratios of DRCD4 and
DRCD8 cells and TCRV5.1, V (5.2 +
5.3), V8 family and Va12.1 cells
increased at the onset of disease and gradually
decreased during vancomycin (VM) therapy.
Symbols in C are: (LI) normal; () MRSA
infection with nephritis; (LI) before onset 3/28;() at Onset 7/3; (E:) during VM therapy 8/11;() during VM therapy 10/28.
We used FACS scanning to compare the T cell subsets and the
frequency of the V region of TCR in patients with MRSA
infection with nephritis to those in patients without nephritis or
IgA nephropathy, and control subjects. Increases in DRCD4
and DRCD8 T cells, and TCRV cells were found in patients
with MRSA infection with nephritis. In one case (case 3), we
followed the changes in the V regions before and after the onset
of glomerulonephritis. Ratios of TCRV cells, especially
V5.1 cells, were significantly increased after the onset and
gradually decreased during vancomycin treatment. Interestingly,
subsets of the increased TCRV cells were mainly DN cells. In
all cases combined, subsets of the TCRDN and TCRCD4
cells were increased (Fig. 5). These TCRDN cells have been
reported to be markedly expanded in patients with autoimmune
diseases [29—32].
Though we measured only 5 of the 21 reported V0s [33, 34], our
results showed V0 (5.2 + 5.3), 5.1, and 6.7k cells were
increased significantly in patients with MRSA infection with
nephritis, compared to those in normal individuals. The V
specificities of the SEs for human and murine V0s have been
of SARN At the onset During vancomycin therapy
10.1 10.0
3/28
uus+ cells
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CD4-CD8÷ CD4+C08+ CID4—C08- C04+CD8— CD4-CD8+ CD4+CID8+ CD4-CD8— CL4+CD8-
Fig. 4. Subsets of TCR J7135. 1 + cells before onset
and during the disease. The subsets of increased
cells were mainly CD4CD8(DN) cells. The
ratio of these TCR V05.1 DN cells at the onset
of nephritis increased fivefold compared to that
before onset. Symbols are: (E)CD4CD8;
(D)CD4CD8-; ()CD4CD8;(l)CD4CD8.
Fig. 5. Subsetsof TCR V cells in MRSA infection with nephritis. Increased subsets in patients with MRSA infection with nephritis were TCR DN cells
and TCR CD4 cells. < 0.05. Data (percentages of cells) are expressed as mean SE. Symbols are: (•) MRSA infection with nephritis, N = 10;(E) Normal, N = 10; (Li) MRSA infection without nephritis.
summarized by Herman et al [13]. The SEs found in these patients
were mainly SE-C, A, and TSST-1. It is well known that SEs
activate specific TCR Vs positive cells, and that they also activate
several TCR Vs. Finding specific activation of multiple TCR VEs
consequently suggests an involvement of superantigen in the
pathogenesis of this form of glomerulonephritis.
The limitations of this study are measurement of TCR V
cells by FACS scan, because the V specificity of some toxins in
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Fig. 6. Amounts of IgA-ICs (A) and IgG-ICs (B) in patients with MRSA
infection with nephritis, without nephritis, and nonnal individuals. In pa-
tients with MRSA infection with nephritis, levels of IgA-ICs were signif-
icantly higher than those in patients with MRSA infection without
nephritis and normal individuals (P < 0.05).
human has been evaluated with a limited number of available
antibodies to human Vs. Therefore there may be nephritis
patients without significantly increased TCR V, cells. However,
it seems likely that measurement of TCR cells by FACS scan
is better than that of mRNA levels of V genes by PCR, because
TCR V expression can be more directly and accurately esti-
mated by FACS scan.
Recently, Friedman et al have suggested a potential role for
microbial superantigens in the pathogenesis of systemic autoim-
mune disease [35]. The microbial superantigens might promote an
abnormal form of cognate T helper-B cell interaction analogous
to that which may occur during graft versus host disease, and
cause B cell activation and systemic autoimmunity. The resting
human B cells bind microbial superantigens and present them to
superantigen-reactive autologous T helper cells, resulting in T cell
activation and polyclonal 1gM and IgG production. In our case,
although polyclonal activation of IgA and IgG occurred, we did
not detect autoantibodies in the patients. The reasons why
superantigens induce the polyclonal activations of IgA and IgG,
and not 1gM is not clear. Superantigens may selectively activate
the T cells that release class-switching lymphokines [36—38].
The histopathologic findings by immunofluorescence micros-
copy in the patients with MRSA infection with nephritis resemble
those seen in IgA-related nephropathies, such as IgA nephropathy
and Henoch-SchOnlein purpura nephritis. We compared the T
cell subsets and frequency of the V region of TCR in patients
with MRSA infection with nephritis to those in patients with IgA
nephropathy, and there were significant differences between the
two patient groups.
In these patients with MRSA infections with nephritis, one of
the characteristic features of MRSA infection is susceptibility to
prolonged septicemia. This is an important precondition for the
development of glomerulonephritis, because SEs may be in the
circulation and may activate T cells for a prolonged period.
Interestingly, in many patients with MRSA infection without
nephritis, the ratios of TCR cells were significantly lower
than those in patients with MRSA infection with nephritis. These
phenomena suggest that clonal suppression or deletion by SEs
may occur in patients with MRSA infection without nephritis.
Some evidence suggests that superantigens occasionally depress
the immune system. The T cell clones stimulated by superantigens
often disappear or become inactive after being stimulated [32].
The factors that determine which patients will or will not develop
glomerulonephritis remain unknown; there may be differences in
the immunogenetic background of patients which contribute to
this susceptibility [39, 40].
Though superantigens induce B cell activation both polyclonal
and Ag-specific Ab responses [34], we could not detect SEs in the
glomeruli or autoantibodies, such as a-GBM Abs, anti-nuclear
Abs, cryoglobulins or ANCA. Further studies are necessary to
investigate the nature of ICs, including the other autoantibodies
deposited in the glomerulonephritis.
From the above observations, we speculate that the nephritis
occurring during an MRSA infection may be induced by superan-
tigens. These may be causing the production of high levels of
cytokines, and the polyclonal activation of IgG and IgA, resulting
in the formation of ICs containing IgA and IgG in the circulation.
These changes may result in glomerulonephritis and vasculitis.
However, further work will be required to clarify the role and
mechanism of these superantigens in the pathogenesis of glomer-
ulonephritis.
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